Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
| ▸ | NPY1R | P25929 | 1/20 | 0.47 |
| ▸ | NPY2R | P49146 | 1/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.42 |
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | APEX1 | P27695 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | GRK6 | P43250 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6330513 | 0.87 | L3MBTL1 (0.55) | MAPTL3MBTL1TDP1ALDH1A1FFAR1 | |
| SCHEMBL6329116 | 0.81 | MAPT (0.51) | MAPTL3MBTL1TDP1ALDH1A1NPY1R | |
| SCHEMBL6326257 | 0.81 | MAPT (0.51) | MAPTL3MBTL1TDP1ALDH1A1NPY1R | |
| SCHEMBL6335374 | 0.79 | STAT3 (0.54) | MAPTTDP1ALDH1A1ALOX5PTGDR2 | |
| SCHEMBL6325802 | 0.79 | LMNA (0.46) | MAPTL3MBTL1TDP1ALDH1A1KDM4E | |
| SCHEMBL6333062 | 0.78 | ALOX5 (0.43) | L3MBTL1ALDH1A1ALOX5KDM4E | |
| SCHEMBL7046401 | 0.75 | FFAR1 (0.76) | MAPTL3MBTL1ALDH1A1FFAR1APEX1 | |
| SCHEMBL5726659 | 0.75 | L3MBTL1 (0.49) | MAPTL3MBTL1TDP1ALDH1A1NPY1R | |
| SCHEMBL6370493 | 0.74 | KIF11 (0.49) | MAPTALDH1A1ALOX5KDM4E | |
| SCHEMBL28743860 | 0.71 | ALOX5 (0.60) | MAPTL3MBTL1ALDH1A1ALOX5KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050014805-A1 | Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity | BAYER PHARMACEUTICALS CORPORATION | 2005-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050014805-A1 | Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity | GPR119, EGLN3, PC | MAPT 3022/4885L3MBTL1 1973/4885TDP1 4209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.